1. Name the major histologic subtypes of lung cancer, describe TNM classification for staging NSCLC.

2. Identify patients at risk for pulmonary complications after lung resection.

3. Review biomarkers used in targeted therapy for NSCLC treatment.

Session date: 
09/04/2018 - 6:45am to 7:30am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Caitlin Snyder, MD